Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Pierre Gravier

CFO at Ptc Therapeutics, Inc. (PTCT)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $653K

Reported trades

Filed Stock Type Shares Price Value Since
Jul 16SEC PTCTPtc Therapeutics, Inc. Sell Plan 3,49483,986 held (−4%) $80.35 $281K -26.3%
Feb 20SEC PTCTPtc Therapeutics, Inc. Sell Plan 2,99287,318 held (−3%) $69.36 $208K -14.6%
Jan 8SEC PTCTPtc Therapeutics, Inc. Sell Plan 2,13990,310 held (−2%) $76.95 $165K -23.0%
  • Sell

    CFO Pierre Gravier sold $281K of PTCT at $80.35 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Pierre Gravier sold $208K of PTCT at $69.36 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Pierre Gravier sold $165K of PTCT at $76.95 — pre-scheduled 10b5-1 plan sale.